Eyestem
Signal active
Organization
Contact Information
Overview
Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell therapy and ophthalmology experts. It also boasts a world class advisory board and we have built collaborations with pioneers and leaders in the space. Our long-term vision is to create a global and scalable cell therapy platform to treat incurable diseases. We are developing a cell therapy platform to produce consistent, quality products over the next few years, concentrating on in vitro efficacy and safety.
About
Industries
Biotechnology
Founded
2016
Employees
11-50
Headquarters locations
India, Asia
Social
N/A
Profile Resume
Eyestem headquartered in India, Asia, operates in the Biotechnology sector. The company focuses on Biotechnology and has secured $76.9M in funding across 12 round(s). With a team of 11-50 employees, Eyestem is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Eyestem, raised $6.4M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
7
Lead Investors
0
Total Funding Amount
$6.4M
Details
3
Eyestem has raised a total of $6.4M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Seed | |||
| 2021 | Seed | |||
| 2022 | Early Stage Venture | 6.4M |
Investors
Eyestem is funded by 20 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Natco Pharma | - | FUNDING ROUND - Natco Pharma | 6.4M |
| Anurag Bagaria | - | FUNDING ROUND - Anurag Bagaria | 6.4M |
| Eyestem | - | FUNDING ROUND - Eyestem | 6.4M |
| Karan Bagaria | - | FUNDING ROUND - Karan Bagaria | 6.4M |
Recent Activity
There is no recent news or activity for this profile.